B0T.F PROMIMIC AB
- Market cap
- EUR 14.1M
- P/E
- -
- P/B
- 2.77x
- ROE
- -18.2%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is B0T.F undervalued?
Graham numberThe Graham number of PROMIMIC AB cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
PROMIMIC AB fundamental analysis
No fundamental analysis for PROMIMIC AB yet.
PROMIMIC AB stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About PROMIMIC AB
Promimic AB (publ) engages in the manufacturing, marketing, and sale of biomaterials for improved osseointegration in the orthopedic and dental implants markets in Sweden. It offers HAnano surface which combines several properties that are known to improve osseointegration into one unique surface modification; and nano-sized crystalline powder or suspension hydroxyapatite can be used in r and d, as an ingredient in bone substitutes or as a chromatography material. The compan…
Full company profilePROMIMIC AB financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
PROMIMIC AB annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 8.07M | 16.2M | 37.1M | 44.0M | 44.4M | 41.7M |
| Gross Profit | 7.61M | 16.6M | 38.5M | 48.0M | 44.2M | 38.2M |
| Operating Income | -15.4M | -16.4M | -10.0M | -8.78M | -9.28M | -10.1M |
| EBITDA | - | -11.9M | -3.61M | -3.70M | -1.97M | -3.72M |
| Net Income | -15.2M | -15.9M | -9.22M | -12.6M | -8.75M | -9.95M |
| EPS | -0.87 | -0.86 | -0.49 | -0.66 | -0.46 | -0.53 |
| Balance Sheet | ||||||
| Total Assets | 32.2M | 92.8M | 92.9M | 88.1M | 75.7M | 68.8M |
| Total Liabilities | 9.60M | 11.5M | 16.2M | 18.2M | 16.6M | 14.1M |
| Shareholders' Equity | 22.6M | 81.3M | 76.7M | 69.9M | 59.1M | 54.7M |
| Cash & Short-term Investments | 8.72M | 58.8M | 50.3M | 35.8M | 20.6M | 19.8M |
| Cash Flow | ||||||
| Operating Cash Flow | -14.6M | -12.3M | -3.75M | -10.4M | -4.20M | 852K |
| Capital Expenditure | 869K | 10.5M | 9.37M | 9.99M | 8.82M | 0.00 |
| Free Cash Flow | -15.5M | -22.8M | -13.1M | -20.4M | -13.0M | 852K |
| Ratios | ||||||
| ROE | -67.3% | -19.5% | -12.0% | -18.0% | -14.8% | -18.2% |
| ROA | -47.2% | -17.1% | -9.9% | -14.3% | -11.6% | -14.5% |
| Net Profit Margin | -188.3% | -98.0% | -24.9% | -28.5% | -19.7% | -23.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
PROMIMIC AB dividends
PROMIMIC AB has not paid dividends in the last 5 fiscal years.
Who owns PROMIMIC AB
- Insiders 76.69%
- Institutions 18.81%
- Public & others 4.50%
- Shares outstanding 18.9M
- Free float 18.7M
PROMIMIC AB company profile
- Company name
- PROMIMIC AB
- Ticker
- B0T.F
- ISIN
- SE0017487242
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 17
- Fiscal year end
- December
- Address
- Entreprenörsstråket 10, Mölndal, Sweden, 431 53
- Phone
- 46 31 16 08 60
- Website
- promimic.com
About PROMIMIC AB
Promimic AB (publ) engages in the manufacturing, marketing, and sale of biomaterials for improved osseointegration in the orthopedic and dental implants markets in Sweden. It offers HAnano surface which combines several properties that are known to improve osseointegration into one unique surface modification; and nano-sized crystalline powder or suspension hydroxyapatite can be used in r and d, as an ingredient in bone substitutes or as a chromatography material. The company was incorporated in 2004 and is headquartered in Mölndal, Sweden.
PROMIMIC AB management
5- Mr. Magnus LarssonChief Executive Officer · born 1963
- Mr. Ulf BrogrenChief Commercial Officer · born 1973
- Ms. Heidi BaderChief Financial Officer · born 1981
- Mr. Per KjellinChief Technology Officer · born 1972
- Mr. Christopher R. WhitfieldCEO of Promimic Inc · born 1967